Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong-Mo Ahn

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry|March 17, 2004
Kinetic and structural consequences of the leaving group in substrates of a class C beta-lactamaseYong-Mo Ahn, R F Pratt
Cell Chemical Biology|March 18, 2017
Elevation of Fumarate Levels Compromise Redox Control and Viability in Mycobacterium tuberculosisYong-Mo Ahn, Helena I Boshoff
STAR Protocols|January 4, 2023
Liquid chromatography-mass spectrometry-based protocol to measure drug accumulation in Mycobacterium tuberculosis and its host cellYong-Mo Ahn, Richard C Lavin, Shumin Tan, et al.
Bioorganic & Medicinal Chemistry|September 7, 2012
A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cellsHideyuki Ikeuchi, Yong-Mo Ahn, Takuya Otokawa, et al.
ACS Infectious Diseases|December 24, 2025
The Quantification of Drug Accumulation within Gram-Negative BacteriaAmir George, Shivangi, Alexandra Bozan, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The Quantification of Drug Accumulation within Gram-Negative BacteriaAmir George, Shivangi, Alexandra Bozan, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2017
Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD<sup>+</sup>) synthetase inhibitors as potential antitubercular agentsXu Wang, Yong-Mo Ahn, Adam G Lentscher, et al.
Scientific Reports|September 29, 2025
A quantitative high-throughput screening pipeline to identify small molecule inhibitors of Chikungunya nsP2 proteaseShuaizhang Li, Xin Hu, Yong-Mo Ahn, et al.
Angewandte Chemie (International Ed. in English)|October 12, 2022
Redesign of Rifamycin Antibiotics to Overcome ADP-Ribosylation-Mediated ResistanceTian Lan, Uday S Ganapathy, Sachin Sharma, et al.
ACS Infectious Diseases|June 24, 2022
<i>Rickettsia</i> Aglow: A Fluorescence Assay and Machine Learning Model to Identify Inhibitors of Intracellular InfectionAlexander Lemenze, Nisha Mittal, Alexander L Perryman, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry|March 17, 2004
Kinetic and structural consequences of the leaving group in substrates of a class C beta-lactamaseYong-Mo Ahn, R F Pratt
Cell Chemical Biology|March 18, 2017
Elevation of Fumarate Levels Compromise Redox Control and Viability in Mycobacterium tuberculosisYong-Mo Ahn, Helena I Boshoff
STAR Protocols|January 4, 2023
Liquid chromatography-mass spectrometry-based protocol to measure drug accumulation in Mycobacterium tuberculosis and its host cellYong-Mo Ahn, Richard C Lavin, Shumin Tan, et al.
Bioorganic & Medicinal Chemistry|September 7, 2012
A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cellsHideyuki Ikeuchi, Yong-Mo Ahn, Takuya Otokawa, et al.
ACS Infectious Diseases|December 24, 2025
The Quantification of Drug Accumulation within Gram-Negative BacteriaAmir George, Shivangi, Alexandra Bozan, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The Quantification of Drug Accumulation within Gram-Negative BacteriaAmir George, Shivangi, Alexandra Bozan, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2017
Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD<sup>+</sup>) synthetase inhibitors as potential antitubercular agentsXu Wang, Yong-Mo Ahn, Adam G Lentscher, et al.
Scientific Reports|September 29, 2025
A quantitative high-throughput screening pipeline to identify small molecule inhibitors of Chikungunya nsP2 proteaseShuaizhang Li, Xin Hu, Yong-Mo Ahn, et al.
Angewandte Chemie (International Ed. in English)|October 12, 2022
Redesign of Rifamycin Antibiotics to Overcome ADP-Ribosylation-Mediated ResistanceTian Lan, Uday S Ganapathy, Sachin Sharma, et al.
ACS Infectious Diseases|June 24, 2022
<i>Rickettsia</i> Aglow: A Fluorescence Assay and Machine Learning Model to Identify Inhibitors of Intracellular InfectionAlexander Lemenze, Nisha Mittal, Alexander L Perryman, et al.
Pageof 2